Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China
Authors
Keywords
Lamivudine, Adefovir, Entecavir, Probabilistic Sensitivity Analysis, HBeAg Seroconversion
Journal
CLINICAL DRUG INVESTIGATION
Volume 35, Issue 3, Pages 197-209
Publisher
Springer Nature
Online
2015-02-11
DOI
10.1007/s40261-015-0273-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- Liver Transplantation in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: The Influence of Viral Characteristics on Clinical Outcome
- (2013) Ting-Jung Wu et al. ANNALS OF SURGICAL ONCOLOGY
- Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients
- (2013) Ji-Dong Jia et al. Hepatology International
- Custo-efetividade dos análogos de nucleosídeos/nucleotídeos para hepatite crônica B
- (2013) Alessandra Maciel Almeida et al. REVISTA DE SAUDE PUBLICA
- Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: A pilot study
- (2013) Rong-Quan Fu MEDICAL SCIENCE MONITOR
- Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada
- (2012) Jing He et al. VALUE IN HEALTH
- Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety
- (2011) Man-Fung Yuen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B
- (2011) Zeng Minde et al. LIVER INTERNATIONAL
- Hepatitis B virus DNA levels and outcomes in chronic hepatitis B
- (2010) Chien-Jen Chen et al. HEPATOLOGY
- Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome
- (2010) Wai-Kay Seto et al. JOURNAL OF HEPATOLOGY
- Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis
- (2010) Bin Wu et al. VALUE IN HEALTH
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China
- (2009) Guang Bi YAO et al. Journal of Digestive Diseases
- Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B
- (2009) Maria Buti et al. JOURNAL OF HEPATOLOGY
- Assessment of Total Economic Burden of Chronic Hepatitis B (CHB)-Related Diseases in Beijing and Guangzhou, China
- (2009) Min Hu et al. VALUE IN HEALTH
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
- (2008) Yun-Fan Liaw et al. Hepatology International
- Hepatitis B Virus Infection
- (2008) Jules L. Dienstag NEW ENGLAND JOURNAL OF MEDICINE
- A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
- (2008) D Eldon Spackman et al. PHARMACOECONOMICS
- The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons
- (2008) Adrian R. Levy et al. VALUE IN HEALTH
- Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach
- (2007) Jean–Michel Pawlotsky et al. GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started